These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 20046144)

  • 1. Strategies to reduce early morbidity and mortality in adults receiving antiretroviral therapy in resource-limited settings.
    Lawn SD; Harries AD; Wood R
    Curr Opin HIV AIDS; 2010 Jan; 5(1):18-26. PubMed ID: 20046144
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Early versus delayed antiretroviral treatment in HIV-positive people with cryptococcal meningitis.
    Eshun-Wilson I; Okwen MP; Richardson M; Bicanic T
    Cochrane Database Syst Rev; 2018 Jul; 7(7):CD009012. PubMed ID: 30039850
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reducing deaths from tuberculosis in antiretroviral treatment programmes in sub-Saharan Africa.
    Lawn SD; Harries AD; Meintjes G; Getahun H; Havlir DV; Wood R
    AIDS; 2012 Nov; 26(17):2121-33. PubMed ID: 22695302
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A decade of antiretroviral therapy in Uganda: what are the emerging causes of death?
    Kiragga AN; Mubiru F; Kambugu AD; Kamya MR; Castelnuovo B
    BMC Infect Dis; 2019 Jan; 19(1):77. PubMed ID: 30665434
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence of Asymptomatic Cryptococcal Antigenemia and Association with Follow-up Risk of Cryptococcal Meningitis and Mortality among HIV Infected Patients in North West India: A Prospective Cohort Study.
    Bhati R; Pramendra S; Sejoo B; Kumar D; Bohra GK; Meena DS; Verma D; Midha NK
    Curr HIV Res; 2021; 19(1):35-39. PubMed ID: 32860359
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tuberculosis-related mortality in people living with HIV in Europe and Latin America: an international cohort study.
    Podlekareva DN; Efsen AM; Schultze A; Post FA; Skrahina AM; Panteleev A; Furrer H; Miller RF; Losso MH; Toibaro J; Miro JM; Vassilenko A; Girardi E; Bruyand M; Obel N; Lundgren JD; Mocroft A; Kirk O;
    Lancet HIV; 2016 Mar; 3(3):e120-31. PubMed ID: 26939735
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term follow-up and survival of antiretroviral-naive patients with cryptococcal meningitis in the pre-antiretroviral therapy era, Gauteng Province, South Africa.
    Park BJ; Shetty S; Ahlquist A; Greenbaum A; Miller JL; Motsi A; McCarthy K; Govender N;
    Int J STD AIDS; 2011 Apr; 22(4):199-203. PubMed ID: 21515751
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Optimum time to start antiretroviral therapy during HIV-associated opportunistic infections.
    Lawn SD; Török ME; Wood R
    Curr Opin Infect Dis; 2011 Feb; 24(1):34-42. PubMed ID: 21150593
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Management of cryptococcal meningitis in sub-saharan Africa.
    Jackson A; Hosseinipour MC
    Curr HIV/AIDS Rep; 2010 Aug; 7(3):134-42. PubMed ID: 20532838
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Causes and outcome of hospitalization among HIV-infected adults receiving antiretroviral therapy in Mulago hospital, Uganda.
    Namutebi AM; Kamya MR; Byakika-Kibwika P
    Afr Health Sci; 2013 Dec; 13(4):977-85. PubMed ID: 24940321
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Optimal timing for antiretroviral therapy initiation in patients with HIV infection and concurrent cryptococcal meningitis.
    Njei B; Kongnyuy EJ; Kumar S; Okwen MP; Sankar MJ; Mbuagbaw L
    Cochrane Database Syst Rev; 2013 Feb; (2):CD009012. PubMed ID: 23450595
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Priorities for Decreasing Morbidity and Mortality in Children With Advanced HIV Disease.
    Frigati L; Archary M; Rabie H; Penazzato M; Ford N
    Clin Infect Dis; 2018 Mar; 66(suppl_2):S147-S151. PubMed ID: 29514237
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Strategies to reduce mortality and morbidity due to AIDS-related cryptococcal meningitis in Latin America.
    Vidal JE; Penalva de Oliveira AC; Dauar RF; Boulware DR
    Braz J Infect Dis; 2013; 17(3):353-62. PubMed ID: 23665012
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Early versus delayed initiation of antiretroviral therapy for concurrent HIV infection and cryptococcal meningitis in sub-saharan Africa.
    Makadzange AT; Ndhlovu CE; Takarinda K; Reid M; Kurangwa M; Gona P; Hakim JG
    Clin Infect Dis; 2010 Jun; 50(11):1532-8. PubMed ID: 20415574
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment for HIV-associated cryptococcal meningitis.
    Tenforde MW; Shapiro AE; Rouse B; Jarvis JN; Li T; Eshun-Wilson I; Ford N
    Cochrane Database Syst Rev; 2018 Jul; 7(7):CD005647. PubMed ID: 30045416
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A clinical and epidemiologic update on the interaction between tuberculosis and human immunodeficiency virus infection in adults.
    Habib AG
    Ann Afr Med; 2009; 8(3):147-55. PubMed ID: 19884690
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predictors of outcome in routine care for Cryptococcal meningitis in Western Kenya: lessons for HIV outpatient care in resource-limited settings.
    Kendi C; Penner J; Koech J; Nyonda M; Cohen CR; Bukusi EA; Ngugi E; Meyer AC
    Postgrad Med J; 2013 Feb; 89(1048):73-7. PubMed ID: 23112217
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Early mortality among adults accessing antiretroviral treatment programmes in sub-Saharan Africa.
    Lawn SD; Harries AD; Anglaret X; Myer L; Wood R
    AIDS; 2008 Oct; 22(15):1897-908. PubMed ID: 18784453
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cryptococcal meningitis screening and community-based early adherence support in people with advanced HIV infection starting antiretroviral therapy in Tanzania and Zambia: an open-label, randomised controlled trial.
    Mfinanga S; Chanda D; Kivuyo SL; Guinness L; Bottomley C; Simms V; Chijoka C; Masasi A; Kimaro G; Ngowi B; Kahwa A; Mwaba P; Harrison TS; Egwaga S; Jaffar S;
    Lancet; 2015 May; 385(9983):2173-82. PubMed ID: 25765698
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cryptococcal antigenemia and its predictors among HIV infected patients in resource limited settings: a systematic review.
    Derbie A; Mekonnen D; Woldeamanuel Y; Abebe T
    BMC Infect Dis; 2020 Jun; 20(1):407. PubMed ID: 32527231
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.